SOST and type 2 diabetes mellitus: Multivariate logistic regression analysis identified serum sclerostin level (odds ratio, 1.127; 95% confidence interval, 1.058-1.200; <i>p</i> < 0.001) as an independent PAS predictor in patients with T2DM.